Chargement en cours...
What have we learned from clinical trials in primary Sjögren's syndrome about pathogenesis?
In vitro and in vivo experimental data have pointed to new immunopathogenic mechanisms in primary Sjögren's syndrome (pSS). The availability of targeted treatment modalities has opened new ways to selectively target these mechanistic pathways in vivo. This has taught us that the role of proinfl...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3157640/ https://ncbi.nlm.nih.gov/pubmed/21371351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar3234 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|